Edward Piller
Internal Medicine · Red Oak, IANPI 1881750370
Payments from drug & device makers
Across 84 payments — averaging $13.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$193
- Boehringer Ingelheim$157
- Novo Nordisk$141
- Amgen$113
- AbbVie$76
- AstraZeneca$64
- plus $357 from 13 others
What the payments were for
- Food & beverage$1,101100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 16 | $193 |
| Boehringer Ingelheim | 12 | $157 |
| Novo Nordisk | 13 | $141 |
| Amgen | 9 | $113 |
| AbbVie | 4 | $76 |
| AstraZeneca | 5 | $64 |
| Merck | 4 | $60 |
| GSK | 4 | $57 |
| Astellas Pharma US Inc | 3 | $47 |
| Sanofi-aventis U.S. LLC | 3 | $45 |
| Johnson & Johnson | 3 | $36 |
| Sanofi Pasteur Inc. | 1 | $19 |
| Novartis | 1 | $17 |
| Boston Scientific | 1 | $17 |
| Lilly USA, LLC | 1 | $14 |
| Amneal Pharmaceuticals LLC | 1 | $13 |
| Radius Health, Inc. | 1 | $13 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $12 |
| Mylan Specialty L.p. | 1 | $8 |
How this compares
$1,101 in reported general payments places this provider in the 85th percentile of 583 internal medicine providers in Iowa.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Esomeprazole Magnesium | 13 | $2,193 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 14 | $535 |
| Levothyroxine Sodium | 16 | $235 |
| Donepezil Hcl | 13 | $152 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 13 | $118 |
| Simvastatin | 20 | $116 |
| Amlodipine Besylate | 12 | $56 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $13 | $23516 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 583 internal medicine providers in Iowa.
Other internal medicine in Red Oak
- Daniela Donoso PenaRed Oak$2K
- Kathleen JonesWest Des Moines$7.6M
- Jennifer KillionAmes,$4.9M
- Lena Rydberg FreeseWest Des Moines$1.8M
- Isam MararCouncil Bluffs$1.5M
- Mark JohnsonMason City$223K
- Ryan TomlinsonDes Moines$209K
- Mark CarlsonSioux City$174K
- Shauna BasenerAmes$127K
- Madalyn WalshIowa City$80K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.